Invesco
APLT

Invesco’s Applied Therapeutics APLT Stock Holding History

Invesco’s Portfolio APLT Stock Details APLT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-51,098
Closed -$25K – 3769
2025
Q1 		$25K Sell
51,098
-2,401
-4% -$1.41K ﹤0.01% 3736
2024
Q4 		$45.8K Sell
53,499
-506,118
-90% -$3.17M ﹤0.01% 3697
2024
Q3 		$4.76M Buy
559,617
+514,357
+1,136% +$3.03M ﹤0.01% 2256
2024
Q2 		$211K Sell
45,260
-494,597
-92% -$2.34M ﹤0.01% 3610
2024
Q1 		$3.67M Buy
+539,857
New +$2.42M ﹤0.01% 2405
2020
Q2 		– Sell
-125,199
Closed -$4.09M – 3639
2020
Q1 		$4.09M Buy
125,199
+84,365
+207% +$3.41M ﹤0.01% 2001
2019
Q4 		$1.11M Buy
+40,834
New +$700K ﹤0.01% 2943

Other funds holding APLT

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $25.1B AUM 22.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Invesco's APLT Position: Q2 2025 in Review

Invesco sold out of Applied Therapeutics (APLT) in Q2 2025, closing a stake of 51,098 shares — an estimated $25K sold.

Invesco first reported a position in APLT in Q4 2019 and held it in 7 quarters. The position peaked at $4.76M in Q3 2024. 75 funds tracked by Wall St. Rank hold APLT as of Q2 2025.

  • Invesco reported no remaining Applied Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Invesco sold 51,098 Applied Therapeutics shares in Q2 2025, an estimated $25K.
  • Invesco first reported a position in Applied Therapeutics in Q4 2019 and held it in 7 quarters.
  • Invesco's Applied Therapeutics position peaked at $4.76M in Q3 2024.
  • 75 funds tracked by Wall St. Rank held Applied Therapeutics as of Q2 2025.

Based on Invesco's 13F filing for Q2 2025, filed 13 Aug 2025.